Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments
Digital Health Global
SEPTEMBER 27, 2023
About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. Automera’s AUTAC platform has broad potential across cancer and other disease areas, with oncology being the initial lead program.
Let's personalize your content